These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 20502642

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vivo quasi-elastic light scattering detects molecular changes in the lenses of adolescents with Down syndrome.
    Sarangi S, Minaeva O, Ledoux DM, Parsons DS, Moncaster JA, Black CA, Hollander J, Tripodis Y, Clark JI, Hunter DG, Goldstein LE.
    Exp Eye Res; 2024 Apr; 241():109818. PubMed ID: 38422787
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP.
    Doran E, Keator D, Head E, Phelan MJ, Kim R, Totoiu M, Barrio JR, Small GW, Potkin SG, Lott IT.
    J Alzheimers Dis; 2017 Apr; 56(2):459-470. PubMed ID: 27983553
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].
    Asai M, Kawakubo T, Mori R, Iwata N.
    Yakugaku Zasshi; 2017 Apr; 137(7):801-805. PubMed ID: 28674290
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model.
    Chen XQ, Salehi A, Pearn ML, Overk C, Nguyen PD, Kleschevnikov AM, Maccecchini M, Mobley WC.
    Alzheimers Dement; 2021 Feb; 17(2):271-292. PubMed ID: 32975365
    [Abstract] [Full Text] [Related]

  • 13. Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome.
    Cataldo AM, Petanceska S, Terio NB, Peterhoff CM, Durham R, Mercken M, Mehta PD, Buxbaum J, Haroutunian V, Nixon RA.
    Neurobiol Aging; 2004 Feb; 25(10):1263-72. PubMed ID: 15465622
    [Abstract] [Full Text] [Related]

  • 14. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
    García-Cerro S, Rueda N, Vidal V, Lantigua S, Martínez-Cué C.
    Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Microvascular changes in Down syndrome with Alzheimer's-type pathology: Insights into a potential vascular mechanism for Down syndrome and Alzheimer's disease.
    Drachman DA, Smith TW, Alkamachi B, Kane K.
    Alzheimers Dement; 2017 Dec; 13(12):1389-1396. PubMed ID: 28627379
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In-vivo anterior segment OCT imaging provides unique insight into cerulean blue-dot opacities and cataracts in Down syndrome.
    Little JA, Mahil AS, Richardson P, Woodhouse JM, Vinuela-Navarro V, Saunders KJ.
    Sci Rep; 2020 Jun 22; 10(1):10031. PubMed ID: 32572106
    [Abstract] [Full Text] [Related]

  • 19. Alzheimer's drugs, APPlication for Down syndrome?
    Sokol DK, Lahiri DK.
    Ageing Res Rev; 2024 Apr 22; 96():102281. PubMed ID: 38513771
    [Abstract] [Full Text] [Related]

  • 20. Exploring Alzheimer molecular pathology in Down's syndrome cerebrospinal fluid.
    Portelius E, Soininen H, Andreasson U, Zetterberg H, Persson R, Karlsson G, Blennow K, Herukka SK, Mattsson N.
    Neurodegener Dis; 2014 Apr 22; 14(2):98-106. PubMed ID: 24992945
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.